Patel Kinnari Insider Trading Activity

Average Profitability
84.02%
Insider Buys Quantity
3
Insider Buys Sum
$104,011.50
Insider Sells Quantity
8
Insider Sells Sum
$2.46M

Insider Activity of Patel Kinnari

Biography of Patel Kinnari

No biography is available at this moment.

2025-05-20SaleRocket Pharmaceuticals, Inc.
RCKT
See Remarks
767
0.0007%
$6.45$4,944-50.8%
2025-05-16SaleRocket Pharmaceuticals, Inc.
RCKT
See Remarks
1,409
0.0013%
$6.53$9,198-47.85%
2025-04-09PurchaseRocket Pharmaceuticals, Inc.
RCKT
See Remarks
21,099
–
$0$0-37.04%
2025-02-21SaleRocket Pharmaceuticals, Inc.
RCKT
See Remarks
6,078
0.0056%
$10.58$64,305-67.53%
2024-11-21SaleRocket Pharmaceuticals, Inc.
RCKT
See Remarks
4,588
0.005%
$13.05$59,892-66.73%
2024-08-16SaleRocket Pharmaceuticals, Inc.
RCKT
See Remarks
3,989
0.0043%
$18.50$73,812-46.65%
2024-05-16SaleRocket Pharmaceuticals, Inc.
RCKT
See Remarks
4,046
0.0045%
$23.35$94,474-34.85%
2024-02-16SaleRocket Pharmaceuticals, Inc.
RCKT
See Remarks
7,132
0.0079%
$29.84$212,805-34.52%
2023-08-17SaleRocket Pharmaceuticals, Inc.
RCKT
See Remarks
1,534
0.0019%
$15.47$23,733+49.9%
2023-05-17SaleRocket Pharmaceuticals, Inc.
RCKT
See Remarks
1,330
0.0017%
$21.38$28,429+4.85%
2020-12-28SaleRocket Pharmaceuticals, Inc.
RCKT
Chief Operating Officer
33,522
0.061%
$56.72$1.9M-25.28%
2020-03-18PurchaseRocket Pharmaceuticals, Inc.
RCKT
Chief Operating Officer
2,000
0.0036%
$9.50$19,000+168.69%
2018-12-06PurchaseRocket Pharmaceuticals, Inc.
RCKT
Chief Operating Officer
5,675
0.0143%
$14.98$85,012-0.66%
Total: 13
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.